Type:Notice
Citation:86 FR 11921
Reading Time:about a minute or two
Juno Therapeutics, Inc. has submitted a proposal to the Foreign-Trade Zones Board for production activity at its facility in Bothell, Washington. The facility will focus on producing cell therapy products, and the proposal includes plans to utilize foreign-sourced human T-cells, which are duty-free. If approved, this setup could allow Juno to avoid customs duties on certain materials and potentially defer or reduce them on production equipment. Public comments on this proposal are invited until April 12, 2021.
Simple Explanation
Juno Therapeutics wants to make special medicine in Bothell, Washington. They are asking for a special permission that might let them use some ingredients from other countries without paying extra taxes.